There is substantial inter-individual variation in response and adverse reactions to antidepressants, and genetic variation may, in part, explain these differences. GNB3 encodes the β3 subunit of the G protein complex, which is involved in the downstream signalling cascade following monoamine receptor activation. A functional polymorphism in this gene (C825T) has been associated with response to antidepressants. Several lines of evidence suggest that GNB3 moderates improvement in the neurovegetative symptoms of depression (such as sleep and appetite) and related adverse reactions independently of change in core mood symptoms. We here report analysis of data from GENDEP, a part-randomized pharmacogenomic trial, on the outcome of 811 subjects with major depression undergoing treatment with either escitalopram or nortriptyline in which the C825T SNP and three further SNPs in GNB3 were genotyped. The TT genotype was significantly associated with a superior response to nortriptyline and these effects were specific to improvements in neurovegetative symptoms. In addition, the same genotype predicted fewer incidents of treatment-emergent insomnia and greater weight gain on the same drug. Our results are consistent with previous associations with GNB3 and emphasize the importance of signalling genes in antidepressant response.
BaileyMJCoonSLCarterDA (2009) Night/day changes in pineal expression of > 600 genes: central role of adrenergic/cAMP signaling. J Biol Chem284: 7606–7622.
2.
BeckATMendelsonMMockJErbaughJ (1961) An inventory for measuring depression. Arch Gen Psychiatry4: 4561–4571.
3.
BishopJRMolineJEllingrodVLSchultzSKClaytonAH (2006) Serotonin 2 A -1438 G/A and G-protein beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects. Neuropsychopharmacology31: 2281–2288.
4.
BourinMPricaC (2009) Melatonin receptor agonist agomelatine: a new drug for treating unipolar depression. Curr Pharmaceut Design15: 1675–1682.
5.
DemyttenaereKVan GanseEGregoireJGaensEMestersP (1998) Compliance in depressed patients treated with fluoxetine or amitriptyline. Belgian Compliance Study Group. Int Clin Psychopharmacol13: 11–17.
6.
DishyVGuptaSLandauR (2003) G-protein beta(3) subunit 825 C/T polymorphism is associated with weight gain during pregnancy. Pharmacogenetics13: 241–242.
7.
DragoFBusaL (2000) Acute low doses of melatonin restore full sexual activity in impotent male rats. Brain Res878: 98–104.
8.
GueorguievaRKrystalJH (2004) Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry61: 310–317.
9.
HamiltonM (1967) Development of a rating scale for primary depressive illness. Br J Psychiatry6: 278–296.
10.
HaunerHMeierMJockelKHFreyUHSiffertW (2003) Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism. Pharmacogenetics13: 453–459.
11.
HaunerHRohrigKSiffertW (2002) Effects of the G-protein beta3 subunit 825 T allele on adipogenesis and lipolysis in cultured human preadipocytes and adipocytes. Horm Metab Res34: 475–480.
12.
Huezo-DiazPUherRSmithR (2009) Moderation of antidepressant response by the serotonin transporter gene. Br J Psychiatry195: 30–38.
13.
JoycePRMulderRTLutySE (2003) Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline. Int J Neuropsychopharmacol6: 339–346.
14.
KangRHHahnSWChoiMJLeeMS (2007) Relationship between G-protein beta-3 subunit C825T polymorphism and mirtazapine responses in Korean patients with major depression. Neuropsychobiology56: 1–5.
15.
KatoMSerrettiA (2010) Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry15: 473–500.
16.
KatoMWakenoMOkugawaG (2008) Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients. Prog Neuropsychopharmacol Biol Psychiatry32: 1041–1044.
17.
KatzMMKoslowSHFrazerA (1996) Onset of antidepressant activity: reexamining the structure of depression and multiple actions of drugs. Depress Anxiety4: 257–267.
18.
KayumovLBrownGJindalRButtooKShapiroCM (2001) A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome. Psychosom Med63: 40–48.
19.
LaposkyADBassJKohsakaATurekFW (2008) Sleep and circadian rhythms: key components in the regulation of energy metabolism. FEBS Lett582: 142–151.
20.
LeeHJChaJHHamBJ (2004) Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenomics J4: 29–33.
21.
LeeHJPaikJWKangSGLimSWKimL (2007) Allelic variants interaction of CLOCK gene and G-protein beta3 subunit gene with diurnal preference. Chronobiol Int24: 589–597.
22.
MichalsenAFreyUHMerseSSiffertWDobosGJ (2009) Hunger and mood during extended fasting are dependent on the GNB3 C825T polymorphism. Ann Nutr Metab54: 184–188.
23.
MollerMBaeresFM (2002) The anatomy and innervation of the mammalian pineal gland. Cell Tissue Res309: 139–150.
24.
MontgomerySAAsbergM (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry134: 382–389.
25.
RosskopfDMantheyISiffertW (2002) Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein beta3 subunit. Pharmacogenetics12: 209–220.
26.
SerrettiACusinCBenedettiF (2005) Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. Am J Med Genet B Neuropsychiatr Genet137B: 36–39.
27.
SerrettiALorenziCCusinC (2003) SSRIs antidepressant activity is influenced by G beta 3 variants. Eur Neuropsychopharmacol13: 117–122.
28.
SerrettiAMandelliLLorenziC (2007) Serotonin transporter gene influences the time course of improvement of ‘core’ depressive and somatic anxiety symptoms during treatment with SSRIs for recurrent mood disorders. Psychiatry Res149: 185–193.
29.
SiffertWForsterPJockelKH (1999) Worldwide ethnic distribution of the G protein beta3 subunit 825 T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol10: 1921–1930.
30.
SiffertWRosskopfDSiffertG (1998) Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet18: 45–48.
31.
StephensMDonnellyP (2003) A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet73: 1162–1169.
32.
StephensMSmithNJDonnellyP (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet68: 978–989.
33.
TsaiSJYuYWLinCH (2004) Association study of adrenergic beta3 receptor (Trp64Arg) and G-protein beta3 subunit gene (C825T) polymorphisms and weight change during clozapine treatment. Neuropsychobiology50: 37–40.
34.
UherRFarmerAHenigsbergN (2009a) Adverse reactions to antidepressants. Br J Psychiatry195: 202–210.
35.
UherRFarmerAMaierW (2008) Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med38: 289–300.
36.
UherRMaierWHauserJ (2009b) Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. Br J Psychiatry194: 252–259.
37.
WHO (1994) SCAN: Schedules for Clinical Assessment in Neuropsychiatry, Version 2.0. Psychiatric Publishers InternationalGeneva: American Psychiatric Press Inc.
38.
WilkieMJSmithDReidIC (2007) A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression. Pharmacogenet Genomics17: 207–215.
39.
WilleitMPraschak-RiederNZillP (2003) C825T polymorphism in the G protein beta3-subunit gene is associated with seasonal affective disorder. Biol Psychiatry54: 682–686.
40.
ZillPBaghaiTCZwanzgerP (2000) Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment. Neuroreport11: 1893–1897.
